Company Filing History:
Years Active: 2021-2024
Title: Jacque Zwahlen: Innovator in Genome Editing
Introduction
Jacque Zwahlen is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of genome editing, holding 2 patents that focus on enhancing the efficiency of genetic modifications. His work is pivotal in advancing the capabilities of genetic engineering.
Latest Patents
Zwahlen's latest patents include innovative methods, compositions, and kits designed to increase genome editing efficiency. These patents detail methods for editing target genomic regions, repairing DNA breaks via HDR pathways, and inhibiting repair through NHEJ pathways. Additionally, they describe methods for modifying gene or protein expression by administering a genome editing system along with a DNA protein-kinase (DNA-PK) inhibitor. The kits and compositions he developed for editing target genes also incorporate these advanced genome editing systems and DNA-PK inhibitors.
Career Highlights
Jacque Zwahlen is currently associated with Vertex Pharmaceuticals, Inc., where he applies his expertise in genome editing to develop cutting-edge solutions. His work is instrumental in pushing the boundaries of genetic research and therapeutic applications.
Collaborations
Zwahlen collaborates with notable colleagues, including Norzehan Abdul-Manan and David A Newsome. These partnerships enhance the innovative potential of his projects and contribute to the advancement of the field.
Conclusion
Jacque Zwahlen's contributions to genome editing through his patents and work at Vertex Pharmaceuticals, Inc. highlight his role as a key innovator in the field. His research continues to pave the way for future advancements in genetic engineering.